FELZARTAMAB FOR IgA NEPHROPATHY: FINAL RESULTS OF THE IGNAZ STUDY

  Back
FELZARTAMAB FOR IgA NEPHROPATHY: FINAL RESULTS OF THE IGNAZ STUDY
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than January 23, 2025. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/34756b8169830a5a085456dfd3b77562.pdf
Uptal
Patel
10
Jürgen Flöge jfloege@ukaachen.de RWTH Aachen University Hospital Div. Nephrology and Cardiology Aachen Germany
Jonathan Barratt jonathan@jonathan-barratt-consulting.co.uk University of Leicester Dept of Cardiovascular Sciences Leicester United Kingdom
Richard Lafayette czar@stanford.edu Stanford University Stanford Glomerular​ Disease Center Palo Alto, CA United States
Brian Schwartz brian@hibio.com Human Immunology Biosciences, Inc., a Biogen Company Clinical Development South San Francisco, CA United States
Paul Manser paul@hibio.com Human Immunology Biosciences, Inc., a Biogen Company Biometrics South San Francisco, CA United States
Lisa Kivman lisa@hibio.com Human Immunology Biosciences, Inc., a Biogen Company Biomarker and Bioanalytical Sciences South San Francisco, CA United States
Stefan Härtle stefan.haertle@morphosys.com Morphosys AG Clinical Pharmacology Planegg Germany
Nicola Faulhaber Nicola.Faulhaber@morphosys.com Morphosys AG Clinical Development Planegg Germany
Anjali Thakur Anjali.Thakur@morphosys.com Morphosys AG Clinical Development Planegg Germany
Sean Barbour Sean.Barbour@vch.ca University of British Columbia Division of Nephrology Vancouver Canada